| EDITORS
PLEASE NOTE: As a service to reporters who may be working on stories
related to cardiac innovation, cardiac recovery or the mechanical
circulatory support market, ABIOMED will periodically release a media
advisory detailing the stories of patients whose lives were saved
by mechanical circulatory support.
MEDIA ADVISORY September 14, 2004 San Antonio, Texas -- Avimael
Santos was 39 years old when he suffered cardiac arrest and shock
following a procedure to repair a heart valve. Dr. Charles Moore
at the University of Texas Health Science Center implanted the BVS
5000, a temporary heart assist device. The BVS did the pumping for
his heart for two weeks, after which he was switched to a longer-term
device and received a heart transplant at CHRISTUS Transplant Institute
in San Antonio, Texas. Since his transplant, Avimael and his wife
have welcomed a new baby into their family.
Chattanooga, Tennessee - Neil Sharp, 68, has a history of heart
issues. In 1980, he had eight blocked coronary arteries that required
open-heart surgery. Five years later, he needed an additional two
coronary artery bypass grafts (CABGs). In 2001, he experienced another
two blockages. With precious few "targets" left to be
grafted onto, his surgeon, Dr. Richard Morrison at Memorial Hospital
in Chattanooga, Tennessee found one vessel he could graft to and
used a TMR laser to revascularize the rest of the heart. Although
the surgery was successful, he was unable to separate from bypass
and required support on both sides of his heart with the BVS 5000.
After six days on support, his heart's function returned and he
was weaned off the device. Mr. Sharp is feeling well, and has taken
up walking, logging 4 to 6 miles a day. "I'm just blessed,"
he said. "Every day is a bonus day."
Hueytown, Alabama -- Ricky Walton's father had suffered from heart
problems that required him to undergo a double coronary artery bypass.
His mother died of a heart attack. His older brother died of a heart
attack at the age of 44, and his grandmother was one of the first
patients to be implanted with a pacemaker at the University of Alabama
at Birmingham. So when, at the age of 42, Rick experienced numbness
in his arms, he took it seriously: although he'd been about to head
out on a motorcycle trip to Biloxi, instead he drove himself directly
to the hospital. His surgeons, Dr. Shefton Riggins and Dr. Christopher
Jones at Baptist Medical Center, Princeton in Birmingham, Alabama
later told him that it was a good thing he did, because without
immediate intervention in the face of the massive heart attack he'd
suffered, he would have died. The surgical team did six off-pump
coronary artery bypass grafts. The surgery went well, but when he
was being wheeled out of the ICU he ended up going into ventricular
fibrillation, after which his heart was unable to recover. He was
rushed back into the OR and was put on the BVS 5000 on both sides
of his heart for six days, recovered and went home. "Without
the BVS, I don't think I would have had these extra years,"
said Mr. Walton. "And I wouldn't have gotten to see my first
grandson, and he's a blessing," he added. His daughter Amy
had been two months pregnant when Mr. Walton suffered the life-threatening
heart attack. A locksmith, Mr. Walton is back to work and back to
enjoying the things he liked to do before the heart attack. He spends
time with his grandson, enjoys motorcycle trips, and volunteers
at the cardiac unit in the hospital where his life was saved.
Based in Danvers, Massachusetts, ABIOMED, Inc. (pronounced “AB’-EE-O-MED”)
is a leading developer, manufacturer and marketer of medical products
designed to assist or replace the pumping function of the failing
heart. ABIOMED currently manufactures and sells the AB5000™
Circulatory Support System and the BVS® 5000 Biventricular Support
System for the temporary support of all patients with failing but
potentially recoverable hearts. The Company’s AbioCor®
Implantable Replacement Heart is the subject of an initial clinical
trial being conducted under an Investigational Device Exemption
from the United States Food and Drug Administration. The AbioCor
has not been approved for commercial distribution, and is not available
for use or sale outside of the initial clinical trial.
###
Media Contact:
Andrea tenBroek
Communications Specialist
(978) 646-1419
mediarelations@abiomed.com
|